Internal Medicine, Gastroenterology · Sylvania, OH
NPI
1548257876
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5700 Monroe St Unit 103
Sylvania, OH, 43560
Phone (419) 843-7996
Groups this clinician bills Medicare through
Medicare paid, 2024
$138K
6,222 services
Medicare patients, 2024
470
Average age 72
Drug cost, 2024
$2.7M
1,909 prescriptions
Company payments, 2025
$37K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael H Basista was code 99213 (office e&m - established), 201 times for 160 patients. In total Michael H Basista billed 6,222 services in 48 codes, and Medicare paid $138K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 201 | 160 | $61.63 | $12K |
| 43239 Upper GI Endoscopy | Office | 58 | 57 | $74.32 | $4,311 |
| 43235 Upper GI Endoscopy | Facility | 49 | 49 | $79.09 | $3,876 |
| 45385 Colonoscopy - Lesion Removal | Office | 37 | 37 | $205.31 | $7,597 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Office | 36 | 36 | $174.77 | $6,292 |
| 43239 Upper GI Endoscopy | Facility | 36 | 36 | $76.17 | $2,742 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 33 | 33 | $181.56 | $5,991 |
| 99214 Office E&M - Established | Office | 32 | 32 | $90.07 | $2,882 |
| 45385 Colonoscopy - Lesion Removal | Facility | 31 | 30 | $207.29 | $6,426 |
| 43235 Upper GI Endoscopy | Office | 26 | 26 | $77.00 | $2,002 |
| 45380 Lower GI Endoscopy - Other | Office | 21 | 21 | $133.50 | $2,803 |
| 99204 Office E&M - New | Office | 20 | 20 | $122.97 | $2,459 |
| 45378 Lower GI Endoscopy - Other | Facility | 16 | 16 | $131.05 | $2,097 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 14 | 14 | $4.38 | $61.31 |
| 99221 Hospital E&M - Initial | Facility | 14 | 14 | $63.73 | $892 |
By year: 2022 $138K for 5,056 services; 2023 $77K for 1,490 services; 2024 $138K for 6,222 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael H Basista prescribed most often to Medicare patients was Pantoprazole Sodium, with 402 prescriptions and refills. In total Michael H Basista wrote 1,909 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 402 | 746 | 109 | $6,667 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 143 | 143 | 140 | $1,860 |
| Omeprazole Generic | 123 | 280 | 43 | $1,924 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 90 | 101 | 90 | $5,276 |
| Esomeprazole Magnesium Generic | 67 | 116 | 18 | $3,840 |
| Azathioprine Generic | 65 | 134 | 14 | $2,478 |
| Famotidine Generic | 64 | 134 | 20 | $765 |
| Linzess Linaclotide | 62 | 90 | 14 | $51K |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 60 | 60 | 60 | $855 |
| Stelara Ustekinumab | 57 | 96 | Under 11 | $1.6M |
| Magnesium Sulfate Generic | 46 | 46 | Under 11 | $2,467 |
| Amitriptyline Hcl Generic | 46 | 70 | 15 | $458 |
| Creon Lipase/Protease/Amylase | 35 | 50 | Under 11 | $86K |
| Mesalamine Generic | 35 | 79 | Under 11 | $24K |
| Ursodiol Generic | 34 | 91 | Under 11 | $8,377 |
Brand drugs: 487 claims; generic drugs: 1,422 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael H Basista $37K ($37K in general payments such as food, travel and fees) from 17 companies. The largest payer was Madrigal Pharmaceuticals with $28K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 29 | $28K |
| Gilead Sciences, Inc. GILD | 19 | $6,237 |
| Abbvie Inc. ABBV | 46 | $744 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 23 | $405 |
| Phathom Pharmaceuticals, Inc. PHAT | 11 | $209 |
| Aimmune Therapeutics, Inc. | 12 | $163 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $83.63 |
| Janssen Biotech, Inc. JNJ | 3 | $65.39 |
| Pfizer Inc. PFE | 3 | $65.18 |
| Lilly USA, LLC LLY | 2 | $53.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.